| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/12/2009 | US20090042216 Method for purifying proteins and/or biomolecule or protein complexes |
| 02/12/2009 | US20090042212 Detection of primary infections with pathogens |
| 02/12/2009 | US20090042202 Prostate-specific polypeptide pamp and encoding nucleic acid molecules |
| 02/12/2009 | US20090042199 Nucleotide sequences coding lymphocyte adhesion protein for use in treatment of autoimmunity, inflammation and infection |
| 02/12/2009 | US20090042188 Agent for Differentiating Hematopoietic Stem Cell Into Natural Killer Cell Comprising Vdup1 Protein or Gene Encoding the Same, and a Method of Differentiating Hematopoietic Stem Cell Into Natural Killer Cell Using Thereof |
| 02/12/2009 | US20090041896 Use in treatment of paper pulp or animal feeds; enzyme is active over a wide range of temperature and of basic and acid pH |
| 02/12/2009 | US20090041891 Gene Encoding Transcriptional Inducer for Maltase Gene and Maltose Transporter Gene and use Thereof |
| 02/12/2009 | US20090041889 Gene Encoding Protein With Vicinal Diketone or Diacetyl-Reducing Activity and Use Thereof |
| 02/12/2009 | US20090041887 High Protein Soybean Meal |
| 02/12/2009 | US20090041805 Locally administering botulinum toxin powder to a patient using a using a needleless syringe connected to a tank of compressed inert gas, such as helium, for producing a supersonic gas flow; gold, platinum, tungsten or ice crystal carrier; pain is alleviated within 1 to 7 days of administration |
| 02/12/2009 | US20090041804 Foreign nucleic acid molecule encoding multiple costimulatory molecules, such as B7-1 or B7-2 (antigens), intercellular adhesion molecules and leukocyte function associated antigen-3 |
| 02/12/2009 | US20090041797 Modified toxins |
| 02/12/2009 | US20090041796 Surface protein of leptospira |
| 02/12/2009 | US20090041795 Synthetic replikin peptides against pathogenic infection of invertebrates in aquaculture |
| 02/12/2009 | US20090041794 Identification of Hla-A2-Presented T-Cell Epitopes Derived from the Oncofoetal Antigen-Immature Laminin Receptor Protein and Uses Thereof |
| 02/12/2009 | US20090041793 Immunostimulatory Compositions and Uses Thereof |
| 02/12/2009 | US20090041791 for linking drug moieties to ligands; comprises a peptide sequence that is a substrate for an intracellular enzyme, for example a cathepsin, that cleaves the peptide at an amide bond |
| 02/12/2009 | US20090041790 Methods for treating cardiovascular disease using a soluble CTLA4 molecule |
| 02/12/2009 | US20090041787 Chemokine receptor antagonists as therapeutic agents |
| 02/12/2009 | US20090041783 Anti-platelet membrane glycoprotein vi monoclonal antibody |
| 02/12/2009 | US20090041782 Novel serotype streptococcus mutans and utilization of the same |
| 02/12/2009 | US20090041774 Haemophilus influenzae type IV pili |
| 02/12/2009 | US20090041772 Soluble Forms of Hendra and Nipah Virus G Glycoprotein |
| 02/12/2009 | US20090041771 Immunological methods and compositions for the treatment of Alzheimer's disease |
| 02/12/2009 | US20090041769 Extracellular domain of CTLA4, with (a) methionine at position 27 and ending with aspartic acid at position 150 (b) an alanine at position 26 and ending with aspartic acid at position 150 ; binds CD80 and/or CD86 with greater avidity; lupus, lupus erythematosus, and lupus nephritis |
| 02/12/2009 | US20090041756 121p1f1: a tissue specific protein highly expressed in various cancers |
| 02/12/2009 | US20090041752 Compositions and methods for the treatment and diagnosis of immune disorders |
| 02/12/2009 | US20090041744 Dimeric and Multimeric FVIIa Compounds |
| 02/12/2009 | US20090041732 Survivin Peptides As Cancer Vaccines |
| 02/12/2009 | US20090041731 Treatment for Diabetes |
| 02/12/2009 | US20090041718 Methods of Modulating Cytokine Activity; Related Reagents |
| 02/12/2009 | US20090041714 Polymer-factor VIII moiety conjugates |
| 02/12/2009 | US20090041668 Non-invasive localization of a light-emitting conjugate in a mammal |
| 02/12/2009 | US20090041661 Measurement of biosynthesis and breakdown rates of biological molecules that are inaccessible or not easily accessible to direct sampling, non-invasively, by label incorporation into metabolic derivatives and catabolitic products |
| 02/12/2009 | US20090041660 new monoclonal antibodies and binding fragments which recognize and immunoreact with cell surface antigens found on small cell lung cancer (SCLC) cells; antibodies have tumor specificity and are useful for therapy, diagnosis, monitoring, detecting and imaging of SCLC disease |
| 02/12/2009 | CA2695830A1 Transferrin variants and conjugates |
| 02/12/2009 | CA2695813A1 Thiopeptide precursor protein, gene encoding it and uses thereof |
| 02/12/2009 | CA2695811A1 A plant regulatory region that directs transgene expression in the maternal and supporting tissue of maize ovules and pollinated kernels |
| 02/12/2009 | CA2695809A1 Plant bioreactor for the production of interleukin-24 cytokine |
| 02/12/2009 | CA2695805A1 Synthetic pulmonary surfactant peptides |
| 02/12/2009 | CA2695586A1 Immobilisation of chelating groups for immobilised metal ion chromatography (imac) |
| 02/12/2009 | CA2695530A1 Msca1 nucleotide sequences impacting plant male fertility and method of using same |
| 02/12/2009 | CA2695505A1 Znf206: a novel regulator of embryonic stem cell self-renewal and pluripotency |
| 02/12/2009 | CA2695495A1 Meganuclease variants cleaving a dna target sequence from the human interleukin-2 receptor gamma chain gene and uses thereof |
| 02/12/2009 | CA2695476A1 New bnp(1-32) epitope and antibodies directed against said epitope |
| 02/12/2009 | CA2695433A1 Lentiviral gene transfer vectors and their medicinal applications |
| 02/12/2009 | CA2695421A1 Chlamydia antigens |
| 02/12/2009 | CA2694824A1 Immunomodulatory peptides |
| 02/12/2009 | CA2694562A1 Novel orthogonal process for purification of recombinant human parathyroid hormone (rhpth) (1-34) |
| 02/12/2009 | CA2693092A1 Production of 2s canola protein involving ion exchange |
| 02/12/2009 | CA2669453A1 Glucanases, nucleic acids encoding them and methods for making and using them |
| 02/12/2009 | CA2663580A1 Bioactive peptides and method of using same |
| 02/11/2009 | EP2022856A2 Improvements in or relating to binding proteins for recognition of DNA |
| 02/11/2009 | EP2022848A1 A method for identifying, expanding, and removing adult stem cells and cancer stem cells |
| 02/11/2009 | EP2022800A2 Compositions for the therapy and diagnosis of ovarian cancer |
| 02/11/2009 | EP2022798A1 Synthetic pulmonary surfactant peptides |
| 02/11/2009 | EP2022797A2 Nucleic acid and corresponding protein entitled 85P1B3 useful in treatment and detection of cancer |
| 02/11/2009 | EP2022561A1 Immobilisation of chelating groups for immobilised metal ion chromatography (IMAC) |
| 02/11/2009 | EP2022505A2 GLP-1, exendin-4, peptide analogs and uses thereof |
| 02/11/2009 | EP2021799A2 Interleukin-33 (il-33) for the diagnosis and prognosis of cardiovascular disease |
| 02/11/2009 | EP2021493A2 Methods and reagents for detecting susceptibility to graft versus host disease or transplant related mortality |
| 02/11/2009 | EP2021490A2 Rpa optimization |
| 02/11/2009 | EP2021480A1 Method for preparing metal nanoparticle using metal binding protein |
| 02/11/2009 | EP2021475A1 High-affinity antagonists of elr-cxc chemokines |
| 02/11/2009 | EP2021474A2 Rage fusion proteins, formulations, and methods of use thereof |
| 02/11/2009 | EP2021467A1 Chimeric pcsk9 proteins, cells comprising same, and assays using same |
| 02/11/2009 | EP2021466A1 Cloning and expression of a novel phytase |
| 02/11/2009 | EP2021457A2 Probiotic strain and antimicrobial peptide derived therefrom |
| 02/11/2009 | EP2021372A2 Compositions and methods for modulating immune responses |
| 02/11/2009 | EP2021368A1 Derivatized insulin oligomers |
| 02/11/2009 | EP2021367A2 Development of follicle stimulating hormone agonists and antagonists in fish |
| 02/11/2009 | EP2021366A2 Production of proteins carrying oligomannose or human-like glycans in yeast and methods use thereof |
| 02/11/2009 | EP2021365A2 Use of ghrelin splice variant for treating high cholesterol levels or high plasma glucose levels and releated diseases |
| 02/11/2009 | EP2021364A1 Improved antimicrobial peptides |
| 02/11/2009 | EP2021363A1 Polypeptides and polynucleotides encoding the same |
| 02/11/2009 | EP2021362A1 Fluorescent proteins and genes encoding them |
| 02/11/2009 | EP2021361A1 Microfluidic device for controlled aggregation of spider silk |
| 02/11/2009 | EP2021360A1 CYCLODIPEPTIDE SYNTHETASE AND ITS USE FOR SYNTHESIS OF CYCLO(TYR-Xaa) CYCLODIPEPTIDES |
| 02/11/2009 | EP2021359A1 Enzymes for degrading herbicides |
| 02/11/2009 | EP2021358A2 Modified bacteriocins and methods for their use |
| 02/11/2009 | EP2021357A1 Cyclodipeptide synthetases and their use for synthesis of cyclo(leu-leu) cyclodipeptide |
| 02/11/2009 | EP2021356A2 Hiv vaccine |
| 02/11/2009 | EP2021017A2 Method |
| 02/11/2009 | EP1910414A4 Polynucleotides and polypeptides of the il-12 family of cytokines |
| 02/11/2009 | EP1759186A4 Sensor constructs and detection methods |
| 02/11/2009 | EP1701978B1 Use of soluble T-Cadherin for the treatment of metabolic disorders |
| 02/11/2009 | EP1648929B1 Active subfragments of human histidine rich glycoprotein |
| 02/11/2009 | EP1594968B1 Fireproof roller shutters and method for producing a fireproof roller shutter |
| 02/11/2009 | EP1581307A4 Irs modulators |
| 02/11/2009 | EP1572679B1 Crfr1 selective ligands |
| 02/11/2009 | EP1487484B1 Use of mixtures of lipopeptides for vaccine production |
| 02/11/2009 | EP1478236B1 Targeted retrograde gene delivery to motor neurons |
| 02/11/2009 | EP1429800B1 Vaccine and use thereof for treatment of amyotrophic lateral sclerosis |
| 02/11/2009 | EP1409012B1 Methods of inducing a cytotoxic immune response and recombinant simian adenovirus compositions useful therein |
| 02/11/2009 | EP1259536B1 Methods of peptide preparation |
| 02/11/2009 | EP1259258B1 Gm-negative ehv-mutants |
| 02/11/2009 | EP1140164B1 Multivalent immunogenic composition containing rsv subunit composition and influenza virus preparation |
| 02/11/2009 | EP1109577B1 Multicomponent vaccines against Staphylococcus aureus |
| 02/11/2009 | EP1042466B1 Polypeptides, polynucleotides and uses thereof |
| 02/11/2009 | EP0946731B1 Non-m non-o hiv strains, fragments and applications |